Search results
Results From The WOW.Com Content Network
Houston Methodist Willowbrook Hospital, located in Houston, Texas, is one of seven community hospitals that are part of Houston Methodist. It employs more than 2,100 people, has an estimated 1,000 affiliated doctors and admits more than 18,000 patients annually. The hospital serves communities in and around Northwest Houston. [1]
The department previously operated the Willowbrook Storefront. [4] Houston Fire Department (HFD) built a temporary Station #96 at West Greens Road and Mills in 1995. In 1999 a new Station #96 was built at Willow Chase and Breton Ridge to service the Willowbrook Mall area and opened in 2000. [citation needed]
William Bronston was born in March 1939 to Bessarabian-born Jewish American film producer Samuel Bronston (1908–1994) and Ukrainian American pianist Sara "Dony" Bronston (1911–1990). [1]
The Allergy and Immunology Clinical Fellowship Program is open to physicians who are on track to complete an approved internal medicine or pediatric medicine residency program. [32] Fellows are eligible to sit for the Board of Allergy and Immunology certification examination after two years.
Brian Murphy was born in 1942. [3] He completed his undergraduate B.S. degree from Wesleyan University in 1964. He then went on to medical training, completing his M.D. in 1969 at the University of Rochester Medical School, and internship the next year at Stanford University Hospital. [2]
Willowbrook Mall is an enclosed regional mall in Willowbrook, Houston, Texas at the intersection of Texas State Highway 249 and Farm to Market Road 1960. The mall has 6 anchor stores: Dick's Sporting Goods, Dillard's, JCPenney, Macy's, and Nordstrom Rack. In 2000, the mall was the 3rd largest Houston-area retail development based on net ...
Miller graduated from Metairie Park Country Day School in 1965. Miller received his B.S. degree in Biology from Tulane University in New Orleans in 1969, and his M.D. degree from Tulane's School of Medicine in 1973.
Talizumab (TNX-901) is a humanized monoclonal antibody that was under development by Tanox in Houston, Texas as a new-concept therapeutic for allergic diseases. The unique anti-IgE antibody was designed to target immunoglobulin E and IgE-expressing B lymphocytes specifically, without binding to IgE already bound by the high affinity IgE receptors on mast cells and basophils.